New York State Common Retirement Fund reports 6.38% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc.

US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices

DIESES SYMBOL IST NICHT MEHR AKTIV

Security	CPRX / Catalyst Pharmaceuticals, Inc.
Institution	New York State Common Retirement Fund
Latest Disclosed Ownership	90,003 shares
Latest Disclosed Value	$ 2,828,794

On July 29, 2026 - New York State Common Retirement Fund filed a 13F-HR form disclosing ownership of 90,003 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $2,828,794 USD as of June 30, 2026. The entity filed a previous 13F-HR on May 6, 2026 disclosing 84,603 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 6.38% during the quarter. The current value of the position is $2,834,194 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-07-29	2026-06-30	13F	CATALYST PHARMACEUTICALS	COM	14888U101	90,003	5,400	6.38	2,829	35.05	0.0036
2026-05-06	2026-03-31	13F	CATALYST PHARMACEUTICALS	COM	14888U101	84,603	1,492	1.80	2,095	7.99	0.0029
2026-02-12	2025-12-31	13F	CATALYST PHARMACEUTICALS	COM	14888U101	83,111	0	0.00	1,940	18.45	0.0026
2025-11-03	2025-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	83,111	17,915	27.48	1,637	15.77	0.0021
2025-10-08	2025-06-30	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	65,196	-26,805	-29.14	1,415	-36.62	0.0019
2025-08-13	2025-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	65,196	-26,805		1		0.0019
2025-10-08	2025-03-31	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	92,001	55,968	155.32	2,231	196.68	0.0033
2025-05-01	2025-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	92,001	55,968		2		0.0033
2025-10-08	2024-12-31	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	36,033	0	0.00	752	5.03	0.0010
2025-01-31	2024-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	36,033	0		1		0.0010
2025-10-08	2024-09-30	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	36,033	-13,300	-26.96	716	-6.28	0.0010
2024-10-28	2024-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	36,033	-13,300		1		0.0010
2025-10-08	2024-06-30	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	49,333	9,216	22.97	764	19.56	0.0010
2024-07-31	2024-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	49,333	9,216		1		0.0010
2025-10-08	2024-03-31	13F/A-1	Catalyst Pharmaceuticals	Common Stock	14888U101	40,117	-28,887	-41.86	639	-44.87	0.0008
2024-05-07	2024-03-31	13F	Catalyst Pharmaceuticals	Common Stock	14888U101	40,117	-28,887		1		0.0008
2025-10-08	2023-12-31	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	69,004	-3,178	-4.40	1,160	37.49	0.0016
2024-02-01	2023-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	69,004	-3,178		1		0.0016
2025-10-08	2023-09-30	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	72,182	32,026	79.75	844	56.40	0.0012
2023-11-07	2023-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	72,182	32,026		1		0.0012
2025-10-08	2023-06-30	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	40,156	-10,876	-21.31	540	-36.29	0.0007
2023-08-07	2023-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	40,156	-10,876		1		0.0007
2025-10-08	2023-03-31	13F/A-2	CATALYST PHARMACEUTICALS	Common Stock	14888U101	51,032	-17,995	-26.07	846	-34.06	0.0011
2023-05-18	2023-03-31	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	51,032	-17,995		1		0.0011
2023-05-02	2023-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	51,032	-17,995		1		0.0011
2025-10-08	2022-12-31	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	69,027	8	0.01	1,284	44.81	0.0018
2023-01-30	2022-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	69,027	8		1		0.0018
2022-11-08	2022-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	69,019	7,251	11.74	886	104.62	0.0013
2022-08-04	2022-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	61,768	4,711	8.26	433	-8.46	0.0006
2022-07-01	2022-03-31	13F/A-1	CATALYST PHARMACEUTICALS	Common Stock	14888U101	57,057	73	0.13	473	22.54	0.0005
2022-05-05	2022-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	57,057	73		473		0.0005
2022-02-02	2021-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	56,984	-231	-0.40	386	27.39	0.0004
2021-11-02	2021-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	57,215	-19,848	-25.76	303	-31.60	0.0003
2021-08-02	2021-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	77,063	769	1.01	443	25.85	0.0005
2021-05-11	2021-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,294	0	0.00	352	38.04	0.0004
2021-02-08	2020-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,294	0	0.00	255	12.33	0.0003
2020-11-05	2020-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,294	0	0.00	227	-35.51	0.0003
2020-08-07	2020-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,294	0	0.00	352	19.73	0.0004
2020-05-06	2020-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,294	-83,977	-52.40	294	-51.08	0.0004
2020-02-05	2019-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	160,271	63,377	65.41	601	16.70	0.0007
2019-11-07	2019-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	96,894	0	0.00	515	38.44	0.0007
2019-08-09	2019-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	96,894	20,700	27.17	372	-4.37	0.0005
2019-05-08	2019-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,194	0	0.00	389	166.44	0.0005
2019-02-08	2018-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,194	0	0.00	146	-49.31	0.0002
2018-11-07	2018-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,194	0	0.00	288	21.01	0.0003
2018-08-10	2018-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	76,194	1,200	1.60	238	32.96	0.0003
2018-05-10	2018-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	74,994	24,200	47.64	179	-10.05	0.0002
2018-02-13	2017-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	50,794	0	0.00	199	55.47	0.0002
2017-11-06	2017-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	50,794	9,394	22.69	128	12.28	0.0002
2017-08-11	2017-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	41,400	41,400		114		0.0002
2016-11-08	2016-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	0	-20,600	-100.00	0	-100.00
2016-08-10	2016-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	20,600	-48,200	-70.06	15	-81.25	0.0000
2016-05-06	2016-03-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	68,800	0	0.00	80	-52.66	0.0001
2016-02-05	2015-12-31	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	68,800	0	0.00	169	-17.96	0.0003
2015-11-12	2015-09-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	68,800	25,507	58.92	206	15.08	0.0003
2015-08-11	2015-06-30	13F	CATALYST PHARMACEUTICALS	Common Stock	14888U101	43,293	43,293		179		0.0003

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.